New York Health Care Lawyers Who Have Decades Of Combined Experience

Photo of attorneys at Rivas Goldstein, LLP

Avoid common killers of health care M&A deals

On Behalf of | Oct 21, 2025 | Buying and selling health care companies |

Mergers and acquisitions (M&A) in the health care industry can offer significant benefits, such as expanded services and increased market share, but they also come with challenges. Understanding the steps involved and potential pitfalls can help health care leaders to mitigate the impact of these challenges and increase the odds of a successful deal.

What is the common process for an M&A deal in health care?

The M&A process typically begins with negotiations between the parties. During this phase, both sides discuss their goals, expectations, and the potential benefits of the merger or acquisition. Once the parties agree to preliminary terms, they generally review a letter of intent (LOI). This document outlines the basics of the proposed deal, serving as a roadmap for the subsequent stages.

Next, the parties conduct due diligence, investigating each other’s operations, financials, and legal standing. This process helps identify any potential risks or liabilities that could impact the deal. Key areas of focus during due diligence include financial statements and tax records, regulatory compliance, and existing contracts as well as intellectual property and technology assets.

Once due diligence is complete, the parties work on drafting a definitive agreement with the terms and conditions of the transaction. This should include the purchase price, representations and warranties, and any conditions precedent to closing. It is essential to draft a thorough agreement that addresses potential issues to avoid disputes later on.

The final step in the M&A process is closing the deal. This involves executing the definitive agreement and transferring ownership or control as outlined in the contract. Closing can be complex, requiring coordination between legal, financial, and operational teams to help better ensure a smooth transition.

What are some of the most common deal killers for these types of transactions? 

Several issues can derail an M&A deal before it reaches closing. Common deal killers include:

  • Unresolved regulatory or compliance issues

  • Discrepancies uncovered during due diligence

  • Disagreements over valuation or purchase price

  • Cultural clashes between merging entities

It is wise to engage experienced legal counsel to help navigate this process and better ensure a more favorable outcome. Ideally, this is done early in the process. A recent example of two New Jersey based organizations working through a deal fell apart after signing a definitive agreement. It is best to have legal counsel to help provide guidance to better ensure issues are dealt with before making it this far into the deal. By anticipating challenges and fostering a cooperative environment, healthcare businesses can increase the likelihood of a successful M&A deal.

Attorney John Rivas is responsible for this communication.

Archives

FindLaw Network